Featuring: Ankit Bharat, MBBS
Ankit Bharat, MBBS, Chief of Thoracic Surgery at Northwestern Medicine and director of the Lung Transplant program, shares findings that support why lung transplantation should be considered for patients who have developed irreversible lung disease due to COVID-19.
Some of the sickest COVID-19 patients have irreversible lung damage, with little hope of getting off a ventilator, but now there is evidence that a double lung transplant could save their lives. In June, Northwestern Medicine surgeons performed the first known double-lung transplant on a COVID-19 patient in the United States. Since then, seven more COVID-19 patients have received double-lung transplants at Northwestern Medicine – a total of eight - the most performed at any health system in the world. These patients have gone on to recover at a rapid pace.
In a new paper in Science Translational Medicine, Northwestern investigators share findings that support this intervention. It is the first paper to detail why lung transplantation should be considered for patients who have developed irreversible lung disease due to COVID-19. Ankit Bharat, MBBS, shares the findings.
Here are some of the topics Bharat details in this episode:
Google Play Music
Continuing Medical Education Credit
Physicians who listen to this podcast may claim continuing medical education credit after listening to an episode of this program.
Academic/Research, Multiple specialties
At the conclusion of this activity, participants will be able to:
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Northwestern University Feinberg School of Medicine designates this Enduring Material for a maximum of 0.05 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Ankit Bharat, MBBS, has nothing to disclose. Course director, Robert Rosa, MD, has nothing to disclose. Planning committee member, Erin Spain, has nothing to disclose. Feinberg School of Medicine's CME Leadership and Staff have nothing to disclose: Clara J. Schroedl, MD, Medical Director of CME, Sheryl Corey, Manager of CME, Allison McCollum, Senior Program Coordinator, Katie Daley, Senior Program Coordinator, and Rhea Alexis Banks, Administrative Assistant 2.
This article was originally published in the Feinberg School of Medicine Research Center on December 8, 2020.
"One of the most important points of this study is to establish lung transplant as a treatment option in very sick patients (with permanent lung damage and no chance of recovery) which is a big paradigm change in the context of organ transplant."
— Ankit Bharat, MBBS
Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients.